Open Access

Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities

Event: ESC Congress 2021 - The Digital Experience
Topic: Atrial Fibrillation (AF)
Session type: Tutorials
Sponsored by Bristol Myers Squibb and Pfizer
Date: 27 August 2021
Time: 17:30 - 18:30

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

1 presentations in this session

Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities.

Speaker: Associate Professor R. Collins (Dublin, IE)
Speaker: Doctor J. Cosin Sales (Valencia, ES)
Thumbnail

2 speakers from this session

Associate Professor Ronan Collins

Tallaght University Hospital, Dublin (Ireland)
7 presentations
0 follower

Doctor Juan Cosin Sales

HOSPITAL ARNAU DE VILANOVA, Valencia (Spain)
3 presentations
0 follower

Related content

ESC Premium Access

Controversy: can we propose atrial fibrillation ablation as first line therapy?

4 December 2021

This platform is supported by

logo Novo Nordisk